Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells

Cell Growth and Differentiation

Volumn 8, Issue 2, 1997, Pages 213-219

  Combates, Nicholas J ^a,b   Kwon, Paul O ^a   Rzepka, Robert W ^a   Cohen, Dalia ^a  

^a Sandoz Pharma Ltd   (Switzerland)

^b Skin Biology TRC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GLYCOPROTEIN P; NUCLEAR FACTOR; PHORBOL ESTER; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; DNA BINDING; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; MACROPHAGE FUNCTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS;

CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MDR; HUMANS; NUCLEAR PROTEINS; P-GLYCOPROTEIN; PROMOTER REGIONS (GENETICS); TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031014915     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Endicott, J. A., and Ling, V. The Biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
2. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
3. Weinstein, R. S., Grogan, T. M., Kuszak, J. R., Jakate, S. M., Kluskens, L. F., and Coon, J. S. Multidrug resistance gene product (P-glycoprotein) in normal tissue and tumors. In: Advances in Pathology and Laboratory Medicine, pp. 207-233. Mosby-Year Book, Inc., 1991.
4. Goldstein, L. J., Pastan, I., and Gottesman, M. M. Multidrug resistance in human cancer. Grit. Rev. Oncol. Hematol., 12: 243-253, 1992.
5. Goldstein, L. J., Galski, H., Fojo, A. T., Willingham, M., Lai, S., Gazdar, A., Pirker, R., Green, A., Grist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
6. Chaudhary, P. M., and Roninson, I. B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst., 85: 632-639, 1993.
7. Kioka, N., Yamano, Y., Komano, T., and Ueda, K. Heat shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett., 301: 37-40, 1992.
8. Uchiumi, T., Kohno, K., Tanimura, H., Matsuo, K., Sato, S., Uchida, Y., and Kuwano, M. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth & Differ., 4: 147-157, 1993.
9. Bates, S. E., Mickley, L. A., Chen, Y-N., Richert, N., Rudick, J., Biedler, J. L., and Fojo, A. T. Expression of a drug resistant gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation. Mol. Cell. Biol., 9: 4337-4344, 1989.
10. Morrow, C. S., Nakagawa, M., Goldsmith, M., Madden, M. J., and Cowan, K. H. Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells. J. Biol. Chem., 269: 10739-10746, 1994.
11. Combates, N. J., Rzepka, R. W., Chen, Y. P., and Cohen, D. NF-IL6, a member of the C/EBP family of transcription factors binds and transactivates the human MDR1 gene promoter. J. Biol. Chem., 269: 29715-29719, 1994.
12. Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., and Akira, S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA, 90: 2207-2211, 1993.
13. Kishimoto, T., Taga, T., and Akira, S. Cytokine signal transduction. Cell, 76: 253-262, 1994.
14. Cao, Z., Umek, R. M., and McKnight, S. L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev., 5: 1538-1552, 1991.
15. Hsu, W., and Chen-Kiang, S. Convergent regulation of NF-IL6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. Mol. Cell. Biol., 13: 2515-2523, 1993.
16. Cooper, C. L., Berrier, A. L., Roman, C., and Calame, K. L. Limited expression of C/EBP family proteins during B lymphocyte development. J. Immunol., 153: 5049-5058, 1994.
17. Diehl, A. M., Michaelson, P., and Yang, S. Q. Selective induction of CCAAT/enhancer binding protein isoforms occurs during rat liver development. Gastroenterology, 106: 1625-1637, 1994.
18. Chandrasekaran, C., and Gordan, J. I. Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein α expression in the gut epithelium of normal and transgenic mice. Proc. Natl. Acad. Sci. USA, 90: 8871-9975, 1993.
19. Piontkewitz, Y., Enerback, S., and Hedin, L. Expression and hormonal regulation of the CCAAT enhancer binding protein-α during differentiation of rat ovarian follicles. Endocrinology, 133: 2327-2333, 1993.
20. Natsuka, S., Akira, S., Nishio, Y., Hashimoto, S., Sugita, T., Isshiki, H., and Kishimoto, T. Macrophage differentiation specific expression of NFIL6, a transcription factor for interleukin 6. Blood, 79: 460-466, 1992.
21. Sundstrom, C., and Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line U937. Int. J. Cancer, 17:565-577, 1976.
22. Gidlund, M., Orn, A., Pattengale, P. K., Jansson, M., Wigzell, H., and Nilsson, K. Natural killer cells kill tumour cells at a given stage of differentiation. Nature (Lond.), 292: 848-850, 1981.
23. Hass, R., Lonnemann, G., Mannel, D., Topley, N., Hartmann, A., Kohler, L., Resch, K., and Goppelt-Strube, M. Regulation of TNF-α, IL1 and IL6 synthesis in differentiating human monoblastoid leukemic U937 cells. Leuk. Res., 15: 327-339, 1991.
24. Taimi, M., Dornand, J., Nicolas, M., Marti, J., and Favero, J. Involvement of CD4 in interleukin-6 secretion by U937 monocytic cells stimulated with the lectin jacalin. J. Leuk. Biol., 55: 214-220, 1994.
25. Wright, S. D., Levin, S. M., Jong, M. T. C., Chad, Z., and Kabbash, L. G. CR3 (CD11D/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med., 169: 175-183, 1989.
26. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Washington DC), 249: 1431-1433, 1990.
27. Ciafriglia, M., Willingham, M. C., Tombesi, M., Scagliotti, G. V., Frasca, G., and Chersi, A. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells. Int. J. Cancer, 56: 153-160, 1994.
28. Williams, S. C., Cantwell, C. A., and Johnson, P. F. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev., 5: 1553-1567, 1991.
29. 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor. J. Biol. Chem., 268: 15681-15688, 1993.
30. Gupta, S., and Gollapudi, S. P-glycoprotein (MDR1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J. Clin. Immunol., 13: 289-301, 1993.
31. Koren, H. S., Anderson, S. J., and Larrick, J. W. In vitro activation of a human macrophage-like cell line. Nature (Lond.), 279: 328-331, 1979.
32. Chaudhary, P. M., and Roninson, I. B. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol. Res., 4: 281-290, 1992.
33. Fine, R. L., Patel, J., and Chabner, B. A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA, 85: 582-586, 1988.
34. Ferrandis, E., and Benard, J. Activation of the human MDR1 gene promoter in differentiated neuroblasts. Int. J. Cancer, 54: 987-991, 1993.
35. Nakatsukasa, H., Silverman, J., Gant, T. W., Evarts, R. P., and Thorgeirsson, S. S. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology, 18: 1202-1207, 1993.
36. Diehl, A. M., and Yang, S. Q. Regenerative changes in C/EBPα and C/EBPβ expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology, 19: 447-456, 1994.
37. McCoy, C., Smith, D., and Cornwell, M. M. 12-O-Tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol., 15: 6100-6108, 1995.
38. Descombes, P., and Schibier, U. A liver enriched transcriptional activator, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell, 67: 569-579, 1991.
39. Marquardt, B., Frith, D., and Stabel, S. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene, 9: 3213-3218, 1994.
40. Hsu, W., Kerppola, T. K., Chen, P-L, Curran, T., and Chen-Kiang, S. Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol. Cell. Biol., 14: 268-276, 1994.
41. Egan, D. A., and Scotto, K. W. Glucocorticoids repress transcription of the hamster class I P-glycoprotein gene through an activator site occlusion mechanism. Proc. Am. Assoc. Cancer Res., 37: 324, 1996.
42. Akira, S., and Kishimoto, T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev., 127: 25-50, 1992.
43. Van, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., and Stern, D. Induction of interleukin 6 (IL6) by hypoxia in vascular cells, central role of the binding site for nuclear factor-IL6. J. Biol. Chem., 270: 11463-11471, 1995.
44. Cornwell, M. M., and Smith, D. E. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem., 268: 19505-19511, 1993.
45. Goldsmith, M. E., Madden, M. J., Morrow, C. S., and Cowan, K. H. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J. Biol. Chem., 268: 5856-5860, 1993.
46. Madden, M. J., Morrow, C. S., Nakagawa, M., Goldsmith, M. E., Fairchild, C. R., and Cowan, K. H. Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J. Biol. Chem., 268: 8290-8297, 1993.
47. van Groenigen, M., Valentijn, L. J., and Baas, F. Identification of a functional initiator sequence in the human MDR1 promoter. Biochim. Biophys. Acta, 1172: 138-146, 1993.
48. Yu, L., Wu, Q., Yang, C-P. H., and Horwitz, S. B. Coordination of transcription factors, NF-Y and C/EBPβ, in the regulation of the mdr1b promoter. Cell Growth & Differ., 6: 1505-1512, 1995.
49. Dignam, J. D., Lebovttz, R. M., and Roeder, R. C. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
50. Ohlsson, H., and Edlund, T. Sequence specific interactions of nuclear factors with the insulin gene enhancer. Cell, 45: 35-44, 1986.
51. Fried, M., and Crothers, D. M. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res., 9: 6505-6525, 1981.
52. Yu, L., Cohen, D., Piekarz, R. L., and Horwitz, S. B. Three distinct nuclear protein binding sites in the promoter of the murine multidrug resistance mdr1b gene. J. Biol. Chem., 268: 7520-7526, 1993.
53. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 5.40-5.41. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
54. Sanger, F., Nicklen, S., and Coulson, A. R. DMA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
55. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T. A nuclear factor of IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J., 9: 1897-1906, 1990.
56. Brasier, A. B. Reporter system using firefly luciferase. In: F. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (eds.), Current Protocols in Molecular Biology, pp. 9.6.10-9.6.14. New York: Greene Publishing Associates and Wiley-Interscience, 1990.
57. Spaete, R. R., and Mocarski, E. S. Regulation of cytomegalovirus gene expression: a and β promoters are trans activated by viral functions in permissive human fibroblasts. J. Virol., 56: 135-143, 1985.